Ferran Nadeu/LinkedIn
Oct 22, 2025, 10:46
Conversation with Ferran Nadeu – Touch Haematology Future Leader 2025
Touch Medical Media shared on LinkedIn:
”A Conversation with Dr Ferran Nadeu – Touch Haematology Future Leaders 2025
As part of our Future Leaders 2025 series, we spoke with Dr Ferran Nadeu (Hospital Clínic de Barcelona, Spain) about his journey in cancer genomics and haematology.
In this interview, he reflects on the influence of mentorship, the excitement of translational discoveries, and how emerging genomic technologies are transforming our understanding of B-cell malignancies.
Read the full interview.”
More winner stories featured in Hemostasis Today.
-
Aug 20, 2026, 04:42Chris Zahner: Why Healthy People Can Have Abnormal Lab Results
-
Aug 20, 2026, 03:57Reza Shojaei: What the First U.S. Freeze-Dried Plasma Approval Means
-
Aug 20, 2026, 01:23Jessica Erley: Understanding Patient Experience Beyond the Clinical Encounter
-
Aug 20, 2026, 01:19Dries De Wolf: Innovative Gene Therapy for Hemophilia B
-
Aug 19, 2026, 19:09Gregory Lip: PFO Closure in Younger Patients With Cryptogenic Stroke
-
Aug 19, 2026, 18:51Filippo Crea: AF and Alzheimer’s Disease – Does the Anticoagulant Choice Matter for the Brain?
-
Aug 19, 2026, 18:42Alan Nurden: How Procoagulant Platelets Relate to Microparticle Release?
-
Aug 19, 2026, 18:25Ivan Centeno Sáenz: FeNO and Biomass Smoke-Associated Chronic Obstructive Pulmonary Disease
-
Aug 19, 2026, 18:10Ahmad Hazri Mohamed Aris: Strengthening Hemophilia Care and Access to Treatment in Fiji